Z250-1344 Screening compound: 1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide

Z250-1344 Screening compound: 1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide
Z250-1344 Screening compound: 1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Z250-1344
1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Z250-1344

Molecular Formula

C24H29N5O2S (C24 H29 N5 O2 S)

Compound Name

1-{4-oxo-7-phenyl-3H,4H-thieno[3,2-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide

IUPAC name

1-{4-oxo-7-phenyl-3H4H-thieno[32-d]pyrimidin-2-yl}-N-[2-(pyrrolidin-1-yl)ethyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1C(NC1=O)=Nc2c1scc2-c1ccccc1)NCCN1CCCC1

InChI

InChI=1S/C24H29N5O2S/c30-22(25-10-14-28-11-4-5-12-28)18-9-6-13-29(15-18)24-26-20-19(17-7-2-1-3-8-17)16-32-21(20)23(31)27-24/h1-3,7-8,16,18H,4-6,9-15H2,(H,25,30)(H,26,27,31)/t18-/m0/s1

InChI Key

KIWQZCACPZUEAI-SFHVURJKSA-N

MDL Number (MFCD)

MFCD27636857

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.59

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.635

Distribution Coefficient, logD

0.395

Water Solubility, LogSw

-3.36

Polar Surface Area

64.988

Acid Dissociation Constant (pKa)

11.09

Base Dissociation Constant (pKb)

9.64

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.80

Z250-1344 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with Z250-1344 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Z250-1344?
Check Price and Availability of Z250-1344, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Z250-1344 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Z250-1344
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Z250-1344
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Z250-1344 available by request